Orthopedic implants may fail owing to different reasons: poor osseointegration at the tissue-implant interface, generation of wear debris, stress and strain imbalance between implant and surrounding tissues, and infections. To ensure success in orthopedics, implant materials must not evoke an undesirable inflammatory response, they must be habitable by bone-forming cells (favoring adhesion of osteoblasts), hinder formation of soft connective tissue (hindering adhesion of fibroblasts), and be anti-infective (discouraging bacterial adhesion). Recent studies have suggested that nanophase materials have a better efficacy as bone implants in favoring osseointegration compared to conventional orthopedic implant materials. This minireview discusses studies on nanophase materials as bone implants, focusing on the effect of these materials in inhibiting bacterial adhesion for the prevention of implant infections. (Int J Artif Organs 2008; 31: 771–6)
SatoM., WebsterT.J.Nanobiotechnology: implications for the future of nanotechnology in orthopaedic applications. Expert Rev Med Devices2004; 1: 105–14.
2.
Abu-AmerY., DarwechI., ClohisyJ.C.Aseptic loosening of total joint replacements: mechanisms underlying osteolysis and potential therapies. Arthritis Res Ther2007; 9(Suppl 1): S6.
3.
CampocciaD., MontanaroL., ArciolaC.R.The significance of infection related to orthopedic devices and issues of antibiotic resistance. Biomaterials2006; 27: 2331–9.
4.
WilliamsD.F.On the mechanisms of biocompatibility. Biomaterials2008; 29: 2941–53.
5.
RuoslahtiE.RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol1996; 12: 697–715.
6.
WebsterT.J., ErgunC., DoremusR.H., SiegelR.W., BiziosR.Specific proteins mediate enhanced osteoblast adhesion on nanophase ceramics. J Biomed Mater Res2000; 51: 475–83.
7.
WebsterT.J., SchadlerL.S., SiegelR.W., BiziosR.Mechanisms of enhanced osteoblast adhesion on nanophase alumina involve vitronectin. Tissue Eng2001; 7: 291–301.
8.
BustanjiY., ArciolaC.R., ContiM., MandelloE., MontanaroL., SamoríB.Dynamics of the interaction between a fibronectin molecule and a living bacterium under mechanical force. Proc Natl Acad Sci U S A2003 11; 100: 13292–7.
9.
ArciolaC.R., BustanjiY., ContiM., CampocciaD., BaldassarriL., SamorìB., MontanaroL.Staphylococcus epidermidis-fibronectin binding and its inhibition by heparin. Biomaterials2003; 24: 3013–9.
10.
CampocciaD., MontanaroL., AgheliH., SutherlandD.S., PiriniV., DonatiM.E., ArciolaC.R.Study of Staphylococcus aureus adhesion on a novel nanostructured surface by chemiluminometry. Int J Artif Organs2006; 29: 622–9.
11.
PopatK.C., EltgrothM., LatempaT.J., GrimesC.A., DesaiT.A.Decreased Staphylococcus epidermis adhesion and increased osteoblast functionality on antibiotic-loaded titania nanotubes. Biomaterials2007; 28: 4880–8.
12.
ShiZ., NeohK.G., KangE.T., WangW.Antibacterial and mechanical properties of bone cement impregnated with chitosan nanoparticles. Biomaterials2006; 27: 2440–9.
13.
MohammadiY., SoleimaniM., Fallahi-SichaniM., GazmeA., Haddadi-AslV., ArefianE., KianiJ., MoradiR., AtashiA., AhmadbeigiN.Nanofibrous poly(epsilon-caprolactone)/poly(vinyl alcohol)/chitosan hybrid scaffolds for bone tissue engineering using mesenchymal stem cells. Int J Artif Organs2007; 30: 204–11.
14.
NairL.S., LaurencinC.T.Nanofibers and nanoparticles for orthopaedic surgery applications. J Bone Joint Surg (Am)2008; 90(Suppl 1): S128–31.
15.
RameshbabuN., Sampath KumarT.S., PrabhakarT.G., SastryV.S., MurtyK.V., Prasad RaoK.Antibacterial nanosized silver substituted hydroxyapatite: synthesis and characterization. J Biomed Mater Res A2007; 80: 581–91.
16.
TsuangY.H., SunJ.S., HuangY.C., LuC.H., ChangW.H., WangC.C.Studies of photokilling of bacteria using titanium dioxide nanoparticles. Artif Organs2008; 32: 167–74.
17.
Ben-NissanB., ChoiA.H.Sol-gel production of bioactive nanocoatings for medical applications. Part 1: an introduction. Nanomed2006; 1: 311–9.
18.
ChoiA.H., Ben-NissanB.Sol-gel production of bioactive nanocoatings for medical applications. Part II: current research and development. Nanomed2007; 2: 51–61.
19.
GuptaR., KumarA.Bioactive materials for biomedical applications using sol-gel technology. Biomed Mater2008; 3: 34005.
20.
CharvilleG.W., HetrickE.M., GeerC.B., SchoenfischM.H.Reduced bacterial adhesion to fibrinogen-coated substrates via nitric oxide release. Biomaterials2008; 29: 4039–44.
21.
ColonG., WardB.C., WebsterT.J.Increased osteoblast and decreased Staphylococcus epidermidis functions on nanophase ZnO and TiO2. J Biomed Mater Res A2006; 78: 595–604.
22.
SchulerM., OwenG.R., HamiltonD.W., de WildM., TextorM., BrunetteD.M., TosattiS.G.P.Biomimetic modification of titanium dental implant model surfaces using the RGDSP-peptide sequence: A cell morphology study. Biomaterials2006; 27: 4003–15.
23.
VandeVondeleS., VorosJ., HubbellJ.A.RGD-grafted poly-L-lysine-graft-(polyethylene glycol) copolymers block non-specific protein adsorption while promoting cell adhesion. Biotechnol Bioeng2003; 82: 784–90.
24.
TosattiS., PaulS.M.D., AskendalA., VandeVondeleS., HubbellJ.A., TengvallP., TextorM.Peptide functionalized poly(L-lysine)-g-poly(ethylene glycol) on titanium: resistance to protein adsorption in full heparinized human blood plasma. Biomaterials2003; 24: 4949–58.
25.
HarrisL.G., TosattiS., WielandM., TextorM., RichardsR.G.Staphylococcus aureus adhesion to titanium oxide surfaces coated with non-functionalized and peptide-functionalized poly(L-lysine)-grafted-poly(ethylene glycol) copolymers. Biomaterials2004; 25: 4135–48.
26.
VariolaF., YiJ.H., RichertL., WuestJ.D., RoseiF., NanciA.Tailoring the surface properties of Ti6Al4V by controlled chemical oxidation. Biomaterials2008; 29: 1285–98.
27.
PowellM.C., KanarekM.S.Nanomaterials health effects-Part 1: background and current knowledge. Wis Med J2006; 105: 16–20.
28.
PowellM.C., KanarekM.S.Nanomaterials health effects-Part 2: uncertainties and recommendations for the future. Wis Med J2006; 105: 18–23.
29.
TamuraK., TakashiN., AkasakaT.Effects of micro/nano particle size on cell function and morphology. Key Eng Mater2004; 254/256: 919–22.
30.
LiuY., HunzikerE.B., LayrolleP., De BruijnJ.D., De GrootK.Bone morphogenetic protein 2 incorporated into biomimetic coatings retains its biological activity. Tissue Eng2004; 10: 101–8.
31.
StigterM., BezemerJ., DeGrootK., LayrolleP.Incorporation of different antibiotics into carbonated hydroxyapatite coatings on titanium implants, release and antibiotic efficacy. J Control Release2004; 99: 127–37.
